Suchergebnisse - "Boonen, Annelies"

PubPharm (47)

1

Work productivity in patients with axial spondyloarthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs : a systematic literature review and meta-analysis

enthalten in: RMD open | 2023

von Rudwaleit, M. | Mørup, M. | Humphries, B. | +4

2

The impact of health literacy : associations with disease activity and medication prescription in patients with rheumatoid arthritis

enthalten in: Rheumatology (Oxford, England) | 2023

von Gorter, A. | Bakker, M. | Ten Klooster, P. | +2

3

Instrument selection for the ASAS core outcome set for axial spondyloarthritis

enthalten in: Annals of the rheumatic diseases | 2023

von Navarro-Compán, V. | Boel, A. | Boonen, A. | +24

4

The effect of anti-inflammatory treatment on depressive symptoms in spondyloarthritis : does the type of drug matter?

enthalten in: Rheumatology (Oxford, England) | 2023

von Webers, C. | Kiltz, U. | Braun, J. | +2

CommentIn: Rheumatology (Oxford). 2023 Jun 1;62(6):2035-2036. - PMID 36534934

5

Development of a web-based decision aid for initiating biological or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) in axial spondyloarthritis

enthalten in: RMD open | 2023

von Beckers, E. | Boonen, A. | van Tubergen, A.

6

Tapering or discontinuation of biological disease-modifying antirheumatic drugs in axial spondyloarthritis : A review of the literature and discussion on current practice

enthalten in: Joint bone spine | 2023

von Webers, C. | Nikiphorou, E. | Boonen, A. | +1

7

New indicator for discordance between patient-reported and traditional disease activity outcomes in patients with early rheumatoid arthritis

enthalten in: Rheumatology (Oxford, England) | 2022

von Pazmino, S. | Lovik, A. | Boonen, A. | +7

8

Biological Disease-Modifying Antirheumatic Drugs and Osteoporotic Fracture Risk in Patients with Rheumatoid Arthritis : A Danish Cohort Study

enthalten in: The American journal of medicine | 2022

von Abtahi, S. | Cordtz, R. | Dreyer, L. | +3

9

Individual-level and country-level socio-economic factors and health outcomes in spondyloarthritis : analysis of the ASAS-perSpA study

enthalten in: Rheumatology (Oxford, England) | 2022

von Capelusnik, D. | Zhao, S. | Boonen, A. | +5

10

Improvement of Functioning and Health With Ixekizumab in the Treatment of Active Nonradiographic Axial Spondyloarthritis in a 52-Week, Randomized, Controlled Trial

enthalten in: Arthritis care & research | 2022

von Walsh, J. | Magrey, M. | Baraliakos, X. | +14

1
2
3
4
5
Nächster »
[5]